logo

Xbiotech Inc (XBIT)



Trade XBIT now with
  Date
  Headline
7/9/2019 8:15:21 AM XBiotech: MRC Funds Phase 2 Multi-Center Study Of Bermekimab
3/5/2019 8:30:59 AM XBiotech Releases Findings For Phase 2 Clinical Study For Bermekimab
12/3/2018 8:16:14 AM XBiotech Announces Successful GMP Audit By Eurofins Amatsigroup
10/26/2018 8:20:26 AM XBiotech Says Awarded 11 New Patents Or Patent Allowances In Q3
9/26/2018 8:06:50 AM XBiotech Reports Granting Of European Patent For Treatment Of Inflammatory Skin Diseases
9/24/2018 8:31:23 AM XBiotech Completes F U.S. Enrollment In Phase 2 Study Evaluating Bermekimab In Patients With Hidradenitis Suppurativa
8/27/2018 8:02:48 AM XBiotech Publishes Breakthrough Findings For Potential Role Of Interleukin-1 Alpha In Risk For Heart Attacks
7/10/2018 8:07:47 AM XBiotech Announces First Patient In Phase 2 Study Of Subcutaneous MABp1 In Patients With Hidradenitis Suppurativa
5/22/2018 8:09:09 AM XBiotech Announces First Patient In Phase 2 Study Of MABp1 In Patients With Atopic Dermatitis
1/26/2018 8:04:22 AM XBiotech Reports Presentation Of Data From Phase 2 Study On MABp1 For Treatment Of Hidradenitis Suppurativa
1/19/2018 8:03:49 AM XBiotech Announces Presentation Of Phase 2 Open Label Extension Study Data Evaluating MABp1